Brief: Tivic Health Systems Q2 Net Income USD -1.931 Million
14/08/2025 21:00
Aug 14 (Reuters) - Tivic Health Systems Q2 operating expenses USD 1.988 million. Q2 revenue USD 86 thousand Q2 gross profit USD 54 thousand Q2 operating income USD -1.934 million Q2 basic EPS USD -2.19
Recent news on Valion Bio
See all newsBrief: Valion Bio Reports First Quarter 2026 Financial Results
Navigate FDA Submission
Brief: Tivic Health Systems Inc To Rebrand As Valion Bio, Ticker To Vbio Effective April 28, 2026
Brief: Tivic Health Systems Inc - Appoints Michael K. Handley As CEO And Board Member Effective March 3, 2026 - SEC Filing
Brief: Tivic Health Systems Enters Stock Purchase Agreement With Tumim Stone Capital